SEC Filing Summary: Form 8-K
Business Context and Reporting Period
Company: Klotho Neurosciences, Inc. (Note: Request metadata listed "Greenland Mines Ltd," but the filing text identifies Klotho Neurosciences, Inc.)
Filing Date: September 19, 2025
Reporting Period: Current report regarding a specific event on September 19, 2025.
Exchange: The Nasdaq Stock Market LLC (Ticker: KLTO, Warrants: KLTOW)
Key Financial Metrics
This filing is a Current Report (Form 8-K) regarding a listing status event. It does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing text does not provide a clear value for any financial metrics.
Material Changes
- Delinquency Notification: The Company received a notice from Nasdaq on September 19, 2025, due to failure to maintain a minimum bid price of $1.00 per share for 30 consecutive business days (Nasdaq Listing Rule 5550(a)(2)).
- Compliance Period: The Company has been granted 180 calendar days, until March 18, 2026, to regain compliance.
- Compliance Requirement: To avoid delisting, the closing bid price must be at least $1.00 for a minimum of ten consecutive business days prior to March 18, 2026.
Outlook, Risks, and Management Commentary
- Delisting Risk: If the Company fails to regain compliance by the deadline, its common stock will be subject to delisting from Nasdaq.
- Management Action: The filing was signed by Joseph Sinkule, Chief Executive Officer, on September 24, 2025.
- Emerging Growth Company: The registrant is identified as an emerging growth company.
Investor Verification Checklist
- Verify the current trading price of KLTO to assess proximity to the $1.00 compliance threshold.
- Monitor the stock's closing bid price over the next 10 consecutive business days to track progress toward compliance.
- Review subsequent filings for any updates on the delisting status or potential reverse stock splits.
- Confirm the company's cash position and operational runway, as this filing does not provide financial health data.